Hyperoxia combined with the B‐cell antagonist rituximab led to intestinal dysbiosis in neonatal mice

The adverse factors impacting the intestinal microbiota of newborns remain to be elucidated. We put forward a hypothesis that hyperoxia in combination with rituximab exhibits a synergistic effect that interferes with neonatal intestinal microbiota. Six C57BL/6J mice, aged 12 weeks and pregnant 18 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kun, Xu, Ya‐Ji, He, Yan, Duan, Cheng‐Xin, Wang, Huai‐Fu, Ding, Wei‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543333/
https://www.ncbi.nlm.nih.gov/pubmed/35524491
http://dx.doi.org/10.1111/1348-0421.12984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543333/
https://www.ncbi.nlm.nih.gov/pubmed/35524491
http://dx.doi.org/10.1111/1348-0421.12984

Ejemplares similares